On the same day a federal judge in Texas blocked the Food and Drug Administration’s approval of mifepristone, a key abortion medication, U.S. District Judge Thomas Rice in Washington state issued an order prohibiting the FDA from pulling access to the drug — conflicting decisions likely to pressure the FDA and the Biden administration to determine how to enforce them.
